Creating a vaccine for aging
Agemica's platform rediscovered standards of care for 17 cancers. It also suggests combinations of the above drugs with anti-aging drug candidates to improve efficacy, reduce side effects, and reduce chances of developing drug resistance.
Such Combination therapies would have pan-anti cancer efficacy ensuring the highest possible patient benefit and market.
Our omics-based technology enables the identification of novel compounds and compound combinations for diseases of aging. This is the third generation of drug discovery where our AI platform analyzes omics data of diseases of aging and suggests potential therapies.
The technology enables to extend patent life of drugs and evergreen blockbuster drugs by finding new indications, combinations and formulations for drugs of interest. This can extend patent life of drugs and save billions for pharma companies yearly.
Our AI-driven approach enables finding anti-aging therapies to address root causes of aging (such as stem cell exhaustion and epigenetic reprogramming) which can prevent diseases of aging such as Neurodegeneration, Cardiovascular, Immune System and Cancer.
Our AI-driven approach enables tissue rejuvenation and bringing back self-renewal capacity of cell back to it.
Agemica is developing drug combinations that reduces your biological age and increases your life span. This can be regarded as a vaccine for Aging, to slow the aging process and prevent you from getting diseases of aging.
Copyright © 2024 Agemica - All Rights Reserved.